Mariner Investment Group’s Pfizer PFE Stock Holding History

Mariner Investment Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-181,815	Closed	-$5.8M	–	171
2016 Q1	$5.11M	Buy	181,815 +86,955	+92%	+$2.48M	1.41%	22
2015 Q4	$2.9M	Buy	94,860 +47,430	+100%	+$1.49M	0.65%	51
2015 Q3	$1.41M	Sell	47,430 -63,451	-57%	-$2.03M	0.29%	97
2015 Q2	$3.53M	Hold	110,881	–	–	0.9%	37
2015 Q1	$3.66M	Buy	110,881 +31,620	+40%	+$1.01M	0.98%	32
2014 Q4	$2.34M	Buy	79,261 +21,291	+37%	+$610K	0.4%	71
2014 Q3	$1.63M	Buy	57,970 +21,080	+57%	+$592K	0.34%	73
2014 Q2	$1.04M	Buy	36,890 +23,188	+169%	+$661K	0.2%	108
2014 Q1	$418K	Buy	+13,702	New	+$409K	0.09%	132

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mariner Investment Group's PFE Position: Q2 2016 in Review

Mariner Investment Group sold out of Pfizer (PFE) in Q2 2016, closing a stake of 181,815 shares — an estimated $5.8M sold.

Mariner Investment Group first reported a position in PFE in Q1 2014 and held it in 9 quarters. The position peaked at $5.11M in Q1 2016. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Mariner Investment Group reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
Mariner Investment Group sold 181,815 Pfizer shares in Q2 2016, an estimated $5.8M.
Mariner Investment Group first reported a position in Pfizer in Q1 2014 and held it in 9 quarters.
Mariner Investment Group's Pfizer position peaked at $5.11M in Q1 2016.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Mariner Investment Group's 13F filing for Q2 2016, filed 3 Aug 2016.